Clinical Trial Update: Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating how Plasmodium falciparum exposure and sickle cell trait influence infection rates and kinetics after IV administration of PfSPZ Chal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• PfSPZ Challenge (P. falciparum sporozoites)

Snippet

Sponsor: Sanaria Inc. | Conditions: Plasmodium Falciparum Malaria, Malaria | Phase 1 | Status: COMPLETED